218 related articles for article (PubMed ID: 8871612)
41. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
Diment S
J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
[TBL] [Abstract][Full Text] [Related]
42. A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
Bevec T; Stoka V; Pungercic G; Cazzulo JJ; Turk V
FEBS Lett; 1997 Jan; 401(2-3):259-61. PubMed ID: 9013899
[TBL] [Abstract][Full Text] [Related]
43. The function of invariant chain in class II-restricted antigen presentation.
Ceman S; Sant AJ
Semin Immunol; 1995 Dec; 7(6):373-87. PubMed ID: 8775463
[TBL] [Abstract][Full Text] [Related]
44. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
45. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
[TBL] [Abstract][Full Text] [Related]
46. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
Nguyen QV; Reyes VE; Humphreys RE
Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
[TBL] [Abstract][Full Text] [Related]
47. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
[TBL] [Abstract][Full Text] [Related]
48. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms.
Shachar I; Elliott EA; Chasnoff B; Grewal IS; Flavell RA
Immunity; 1995 Sep; 3(3):373-83. PubMed ID: 7553001
[TBL] [Abstract][Full Text] [Related]
49. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
50. Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.
Zavašnik-Bergant T; Bergant Marušič M
PLoS One; 2016; 11(3):e0150815. PubMed ID: 26960148
[TBL] [Abstract][Full Text] [Related]
51. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
[TBL] [Abstract][Full Text] [Related]
52. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
[TBL] [Abstract][Full Text] [Related]
53. Requirement for protein synthesis in antigen processing by B cells.
Soreng KM; Moore JC; Sherman MA; Jensen PE
Cell Immunol; 1994 Aug; 157(1):277-90. PubMed ID: 8039248
[TBL] [Abstract][Full Text] [Related]
54. Intracellular localization and association of MHC class I with porcine invariant chain.
Xu FZ; Wu SG; Yu WY
Genet Mol Res; 2013 Mar; 12(1):693-701. PubMed ID: 23546951
[TBL] [Abstract][Full Text] [Related]
55. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
56. MHC molecules protect T cell epitopes against proteolytic destruction.
Mouritsen S; Meldal M; Werdelin O; Hansen AS; Buus S
J Immunol; 1992 Sep; 149(6):1987-93. PubMed ID: 1381392
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
[TBL] [Abstract][Full Text] [Related]
58. Invariant chain p41 mediates production of soluble MHC class II molecules.
Shishido T; Kohyama M; Nakai W; Matsumoto M; Miyata H; Suenaga T; Arase H
Biochem Biophys Res Commun; 2019 Jan; 509(1):216-221. PubMed ID: 30587340
[TBL] [Abstract][Full Text] [Related]
59. In vivo functions mediated by the p41 isoform of the MHC class II-associated invariant chain.
Takaesu NT; Lower JA; Yelon D; Robertson EJ; Bikoff EK
J Immunol; 1997 Jan; 158(1):187-99. PubMed ID: 8977190
[TBL] [Abstract][Full Text] [Related]
60. Cathepsin S activity regulates antigen presentation and immunity.
Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
